COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains.

Acta Derm Venereol

Department of Dermatology, University Hospital Rennes, 2 rue Henri le Guilloux, FR-35000 Rennes, France.

Published: June 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631250PMC
http://dx.doi.org/10.2340/actadv.v102.888DOI Listing

Publication Analysis

Top Keywords

covid-19 vaccination
4
vaccination safety
4
safety patients
4
patients sars-cov-2-induced
4
sars-cov-2-induced chilblains
4
covid-19
1
safety
1
patients
1
sars-cov-2-induced
1
chilblains
1

Similar Publications

The coronavirus disease 2019 (COVID-19) is a fatal disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). To date, several vaccines have been developed to combat the spread of this virus. Mucosal vaccines using food-grade bacteria, such as Lactobacillus spp.

View Article and Find Full Text PDF

Introduction: Vaccine mandates have been used to minimize the duty days lost and deaths attributable to infectious disease among active duty Service members (ADSMs). In response to the global COVID-19 pandemic, in August 2021, the U.S.

View Article and Find Full Text PDF

The attitudes of reproductive-age individuals toward COVID-19 vaccination during pregnancy are still not well understood. We aimed to explore the attitudes toward COVID-19 vaccines during pregnancy and the determinants among the Chinese reproductive-age population. An anonymous cross-sectional study was conducted in China from July 4 to August 11, 2023.

View Article and Find Full Text PDF

Prader-Willi syndrome (PWS) is a genetic disorder associated with baseline respiratory impairment caused by multiple contributing etiologies. While this may be expected to increase the risk of severe COVID-19 infections in PWS patients, survey studies have suggested paradoxically low disease severity. To better characterize the course of COVID-19 infection in patients with PWS, this study analyses the outcomes of hospitalizations for COVID-19 among patients with and without PWS.

View Article and Find Full Text PDF

The Uptake of the Influenza Vaccine in Patients With Cystic Fibrosis: A Retrospective Study.

J Paediatr Child Health

January 2025

Paediatric Respiratory and Sleep Department, Women's and Children's Hospital, Adelaide, South Australia, Australia.

Background: Children with cystic fibrosis are more likely to become severely unwell with influenza-associated illness compared to children without chronic lung disease. The provision of accessible influenza vaccinations is essential in the prevention of infection.

Objectives: To describe the prevalence of the influenza vaccine uptake in children with cystic fibrosis from 2016 to 2020 at a single tertiary paediatric hospital site and determine if the COVID pandemic of 2020 and the introduction of telehealth encounters affected the vaccine uptake.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!